Recombinant therapeutic monoclonal antibodies: Mechanisms of action in relation to structural and functional duality - ScienceDirect
Proof-of-concept experimental therapies of cancer and mechanisms of resistance to anti-cancer drugs | Yosef (Yossi) Yarden's Lab
Cancers | Free Full-Text | Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma | HTML
Frontiers | Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics | Oncology
Frontiers | Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus? | Immunology
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
Monoclonal Antibodies - National Cancer Institute
Spoilt for Choice | Charles River
Frontiers | Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma | Oncology
Future perspectives of therapeutic monoclonal antibodies | Immunotherapy
Neutralizing monoclonal antibodies for treatment of COVID-19 | Nature Reviews Immunology
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
Cancers | Free Full-Text | Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities | HTML
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside | Immunotherapy
Monoclonal antibody - Wikipedia
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma | NEJM
Hunting for antibodies to combat COVID‑19
Passive antibody therapy in COVID-19 | Nature Reviews Immunology
Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis | Respiratory Research | Full Text
Neutralizing monoclonal antibodies for treatment of COVID-19 | Nature Reviews Immunology
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma | HTML
Cancers | Free Full-Text | Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures
Neutralizing monoclonal antibodies for treatment of COVID-19 | Nature Reviews Immunology
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2: Trends in Pharmacological Sciences
